Yamamoto T, Yasuda J, Kanao M, Okada H
Department of Obstetrics and Gynecology, Kyoto Prefectual University of Medicine.
Jpn J Antibiot. 1988 Nov;41(11):1792-6.
A clinical study was carried out on imipenem/cilastatin sodium (IPM/CS) in the perinatal period, and the results obtained are summarized as follows. IPM/CS was given to 5 cases with puerperal intrauterine infection and 2 with puerperal fever. The clinical efficacies were evaluated as good in 6 cases and poor in 1. The clinical efficacy rate was 85.7%. In a bacteriological examination, 9 strains were isolated from 6 cases, and 7 strains were eradicated with an eradication rate of 77.8%. No side effects were observed in any of the cases treated with IPM/CS.
